nasopharyngeal carcinoma by ajcc v8 stage
Showing 1 - 4 of 4
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial (New-mode reduce-volume target IMRT)
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- New-mode reduce-volume target IMRT
- (no location specified)
Oct 18, 2023
Acute Radiation Induced Oral Mucositis in Nasopharyngeal
Recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- Routine oral care
-
Guangzhou, Guangdong, ChinaYu Zeng
May 16, 2023
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in China (Nimotuzumab, Gemcitabine, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- Nimotuzumab
- +3 more
-
Baise, Guangxi, China
- +8 more
Jan 29, 2023
Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )
Not yet recruiting
- Nasopharyngeal Carcinoma by AJCC V8 Stage
- HLX07
- +3 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 23, 2022